<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Opioid Manag</journal-id><journal-id journal-id-type="iso-abbrev">J Opioid Manag</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of opioid management</journal-title></journal-title-group><issn pub-type="ppub">1551-7489</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6476537</article-id><article-id pub-id-type="pmcid-ver">PMC6476537.1</article-id><article-id pub-id-type="pmcaid">6476537</article-id><article-id pub-id-type="pmcaiid">6476537</article-id><article-id pub-id-type="manuscript-id">NIHMS1012399</article-id><article-id pub-id-type="pmid">30629277</article-id><article-id pub-id-type="doi">10.5055/jom.2018.0473</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1012399</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1012399</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Claims Analysis of the Utilization of Tramadol for Acute Pain in Patients Prescribed Buprenorphine/Naloxone for Opioid Use Disorder</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Donovan</surname><given-names initials="K">Kellye</given-names></name><degrees>PharmD, MHA</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kogut</surname><given-names initials="S">Stephen</given-names></name><degrees>PhD, MBA</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Buchanan</surname><given-names initials="A">Ashley</given-names></name><degrees>DrPH, MS</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wen</surname><given-names initials="X">Xuerong</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Crausman</surname><given-names initials="R">Robert</given-names></name><degrees>MD, MMS</degrees><xref ref-type="aff" rid="A2">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Pharmacy Practice, Program in Health Outcomes, College of Pharmacy, University of Rhode Island, Kingston, RI</aff><aff id="A2"><label>2</label>President Trumed Medical Offices, Fall River, MA, Clinical Professor, Alpert School of Medicine, Brown University, Providence, RI</aff><author-notes><corresp id="CR1">Corresponding author contact information: Kellye Donovan, PharmD, MHA, 399 Fry Pond Rd, West Greenwich, RI 02817. Phone: 401-835-7939. <email>kloethen@my.uri.edu</email></corresp></author-notes><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2018</year></pub-date><volume>14</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">333074</issue-id><fpage>407</fpage><lpage>413</lpage><pub-history><event event-type="nihms-submitted"><date><day>16</day><month>02</month><year>2019</year></date></event><event event-type="pmc-release"><date><day>01</day><month>11</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>01</day><month>11</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 23:25:33.200"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1012399.pdf"/><abstract id="ABS1"><sec id="S1"><title>Objective:</title><p id="P1">To determine the prevalence of tramadol prescribing among commercially insured adults receiving medication assisted therapy (MAT) with buprenorphine/naloxone.</p></sec><sec id="S2"><title>Design:</title><p id="P2">We conducted a cross-sectional descriptive study to evaluate the use of tramadol among patients prescribed buprenorphine/suboxone for MAT.</p></sec><sec id="S3"><title>Setting:</title><p id="P3">This study utilized data from 2010 to 2013 Optum&#174; Clinformatics&#174; Data Mart. This cohort is an administrative health claims database from a large national insurer. This data included pharmacy and medical care utilization and information describing patient enrollment.</p></sec><sec id="S4"><title>Patients, Participants:</title><p id="P4">Patients were 12 to 64 years of age and had complete and available medical, pharmacy and administrative records in the Optum Clinformatics Data Mart during study period.</p></sec><sec id="S5"><title>Main Outcome Measures:</title><p id="P5">Patients who received at least one paid claim for buprenorphine/naloxone from 2010 to 2013 and also received at least one overlapping pharmacy dispensing for tramadol were identified for analysis. We determined if the concurrent buprenorphine/naloxone and tramadol dispensings were from the same or a different prescriber.</p></sec><sec id="S6"><title>Results:</title><p id="P6">In this analysis of 18,734 U.S. commercially insured patients receiving MAT with buprenorphine/naloxone, we identified 1,198 (6.4%) patients who received at least one overlapping dispensing for tramadol during a four-year period spanning 2010 through 2013. Among these patients, 266 (1.42%) were co-prescribed buprenorphine/naloxone and tramadol from the same provider.</p></sec><sec id="S7"><title>Conclusions:</title><p id="P7">These results suggest that the use of tramadol among patients receiving buprenorphine/naloxone is not uncommon. Further study is warranted to further determine the benefits and risks associated with the use of tramadol for pain management among patients prescribed buprenorphine/naloxone.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>